Metabolic Targeting of Breast Cancer Cells With the 2-Deoxy-D-Glucose and the Mitochondrial Bioenergetics Inhibitor MDIVI-1

Breast cancer cells have different requirements on metabolic pathways in order to sustain their growth. Triple negative breast cancer (TNBC), an aggressive breast cancer subtype relies mainly on glycolysis, while estrogen receptor positive (ER+) breast cancer cells possess higher mitochondrial oxida...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucantoni, Federico, Dussmann, Heiko, Prehn, Jochen H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141706/
https://www.ncbi.nlm.nih.gov/pubmed/30255019
http://dx.doi.org/10.3389/fcell.2018.00113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141706/
https://www.ncbi.nlm.nih.gov/pubmed/30255019
http://dx.doi.org/10.3389/fcell.2018.00113

Ejemplares similares